279 filings
Page 3 of 14
8-K
coi7jl6m2f5lkmyu
1 Aug 23
Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million
8:04am
8-K
so8mwj idt
27 Jul 23
The Chemours Company Reports Second Quarter 2023 Results and Announces Closure of Titanium Dioxide Plant in Taiwan
9:01pm
8-K
7z5g4 boub6vpk6
26 Jul 23
Chemours Names Joseph Martinko as President, Thermal & Specialized Solutions
7:47am
8-K
5qscn vivvqr
30 Jun 23
Entry into a Material Definitive Agreement
4:30pm
8-K
ivg4wrhnaz0rb5hr6n
6 Jun 23
Company Appoints Jonathan Lock as new CFO and Promotes Matt Abbott to Executive Team as SVP, Chief Enterprise Transformation Officer
6:46am
8-K
io9s ax3v
2 Jun 23
Entry into a Material Definitive Agreement
6:31am
8-K
1auw mrgb3rzr
1 Jun 23
The Chemours Company Agrees to Sell Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific Inc. for $137 Million
4:34pm
SD
fkjkx9ea8klma
31 May 23
Conflict minerals disclosure
4:06pm
8-K
awnm3l mvdc
18 May 23
Departure of Directors or Certain Officers
7:48am
8-K
i5txpyrmeb yyn
27 Apr 23
The Chemours Company Reports First Quarter 2023 Results
4:18pm
8-K
nvyo5
27 Apr 23
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
83qj29
29 Mar 23
Third Amendment to Amended and Restated Receivables Purchase Agreement
4:07pm
8-K
3bmfgc1jg wyxp
23 Mar 23
Business strategies are unchanged as the company promotes top executives
6:48am
8-K
b508jn5lw9y9iph0lyg
16 Mar 23
Chemours Titanium Technologies & Chemical Solutions Business President Resigns; Chemours Begins Talent Search for Backfill & Appoints Interim Leader
7:48am
8-K
0zwjn00l06c
15 Mar 23
Entry into a Material Definitive Agreement
4:14pm
ARS
g9mi5 cm8j8u80sfhzl
10 Mar 23
Annual report to shareholders
5:04pm
DEFA14A
6z8xo80k7wck
10 Mar 23
Additional proxy soliciting materials
5:02pm